Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03613116 · ClinicalTrials.gov registry record · Phase 2
High-dose Vitamin D Supplements in Older Adults
A Phase 2 study of Cognitive Decline and Vitamin D Deficiency, sponsored by University of California, Davis.
- Active
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT03613116 is a Phase 2 study of Cognitive Decline and Vitamin D Deficiency that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 180 participants, below the 1,146-participant average among 61 other Cognitive Decline trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03613116, a Phase 2 study of Cognitive Decline and Vitamin D Deficiency, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This Phase II randomized clinical trial aims to test if supplementation with high dose oral vitamin D will successfully correct vitamin D insufficiency, compared to treatment with standard (RDA) dose vitamin D in a diverse community-based elderly cohort. The effect of high-dose vs. standard-dose vitamin D on altering cognitive trajectories will also be assessed and data will be expected to be used in designing a potential definitive Phase III trial in elderly groups at risk for dementia. A total of 180 elderly persons with longitudinal biomarkers, neuropsychological testing and brain MRI scans will be enrolled, with 152 (\~50 with MCI, 50 with mild AD and 50 with no cognitive impairment) expected to complete the 3½-year study. One-half of each diagnostic group will be randomized to treatment with high-dose vitamin D3 (4,000 IU daily) or to standard dose Vitamin D (600 IU capsule daily + \~200 IU dietary = \~800 IU total/day). Longitudinal MRI analyses will provide an estimate of the treatment effect size on brain atrophy rate. Vitamin D receptor genotype polymorphisms and their impact on response to oral supplementation will also be examined. If vitamin D supplementation improves cognitive outcome, this could have a large impact on the public health, since low vitamin D status is a common, readably treatable condition which may provide a novel window to prevent dementia and AD. Furthermore, the higher prevalence of AD and dementia in African Americans and Latinos could be partially attributable to vitamin D insufficiency.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
Study Locations (1)
California
- University of California, Davis Alzheimer's Disease Center - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03613116
The ClinicalTrials.gov registry entry for NCT03613116 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,146-participant average among 61 other Cognitive Decline trials with a reported enrollment target (84% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT03613116 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03613116 about?
NCT03613116 is a clinical study titled "High-dose Vitamin D Supplements in Older Adults". This Phase II randomized clinical trial aims to test if supplementation with high dose oral vitamin D will successfully correct vitamin D insufficiency, compared to treatment with standard (RDA) dose vitamin D in a diverse community-based elderly cohort. The effect of high-dose vs. standard-dose vit...
What is the current status of trial NCT03613116?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2019-03-18. Estimated completion is 2026-12-31.
What conditions does trial NCT03613116 study?
This clinical trial studies the following conditions: Cognitive Decline, Vitamin D Deficiency.
What interventions are being tested in trial NCT03613116?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03613116?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03613116 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
RECRUITING · Phase 2
-
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
RECRUITING · Phase 2
-
Advancing Postmenopausal Preventive Therapy
ACTIVE NOT RECRUITING · Phase 2
-
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
ACTIVE NOT RECRUITING · Phase 2
-
Dopaminergic Dysfunction in Late-Life Depression
ACTIVE NOT RECRUITING · Phase 2
-
Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.